Gene · 7538
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatial immune scoring system predicts hepatocellular carcinoma recurrence. | Nature | 2025 | 40074893 | PubTator, text mining | PubMed |
| Identification of conserved gene expression changes across common glomerular diseases by spatial transcriptomics. | J Nephrol | 2025 | 40067649 | PubTator, text mining | PubMed |
| Targeting Zfp36 to combat cardiac hypertrophy: Insights into ferroptosis pathways. | Clin Transl Med | 2025 | 40000392 | PubTator, text mining | PubMed |
| Restraint of inflammasome-driven cytokine responses through the mRNA stability protein TTP. | Cell Rep | 2025 | 39982821 | PubTator, text mining | PubMed |
| Effect of tristetraprolin on esophageal squamous cell carcinoma cell proliferation. | Tissue Cell | 2025 | 39954564 | PubTator, text mining | PubMed |
| Role of glucocorticoid receptor expression in Chronic Chagas Cardiomyopathy: implications for inflammation and cardiac hypertrophy. | Front Endocrinol (Lausanne) | 2025 | 39950024 | PubTator, text mining | PubMed |
| Tristetraprolin Family Members and Processing Bodies: A Complex Regulatory Network Involved in Fatty Liver Disease, Viral Hepatitis and Hepatocellular Carcinoma. | Cancers (Basel) | 2025 | 39941720 | PubTator, text mining | PubMed |
| Retraction: ZFP36 binds with PRC1 to inhibit tumor growth and increase 5-Fu chemosensitivity of hepatocellular carcinoma. | Front Mol Biosci | 2025 | 39917411 | PubTator, text mining | PubMed |
| Deletion of smooth muscle ZFP36 promotes neointimal hyperplasia in mice. | Acta Pharmacol Sin | 2025 | 39890944 | PubTator, text mining | PubMed |
| Cytoplasmic mRNA decay controlling inflammatory gene expression is determined by pre-mRNA fate decision. | Mol Cell | 2025 | 39862867 | PubTator, text mining | PubMed |
| Integrative single-cell and multi-omics analyses reveal ferroptosis-associated gene expression and immune microenvironment heterogeneity in gastric cancer. | Discov Oncol | 2025 | 39831925 | PubTator, text mining | PubMed |
| Screening potential diagnostic biomarkers for PLA2R‑associated idiopathic membranous nephropathy by WGCNA analysis and LASSO algorithm. | Ren Fail | 2025 | 39806779 | PubTator, text mining | PubMed |
| Identification of Programmed Cell Death-related Biomarkers for the Potential Diagnosis and Treatment of Osteoporosis. | Endocr Metab Immune Disord Drug Targets | 2025 | 39791175 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis and experimental validation of exosome-related gene signature in steroid-induced osteonecrosis of the femoral head. | J Orthop Surg Res | 2025 | 39789578 | PubTator, text mining | PubMed |
| Adipose ZFP36 protects against diet-induced obesity and insulin resistance. | Metabolism | 2025 | 39761791 | PubTator, text mining | PubMed |
| Nonenzymatic lysine D-lactylation induced by glyoxalase II substrate SLG dampens inflammatory immune responses. | Cell Res | 2025 | 39757301 | PubTator, text mining | PubMed |
| Integrated explainable machine learning and multi-omics analysis for survival prediction in cancer with immunotherapy response. | Apoptosis | 2025 | 39633110 | PubTator, text mining | PubMed |
| ZFP36 Regulates Vascular Smooth Muscle Contraction and Maintains Blood Pressure. | Adv Sci (Weinh) | 2025 | 39589932 | PubTator, text mining | PubMed |
| Tristetraprolin-mediated mRNA destabilization regulates basophil inflammatory responses. | Allergol Int | 2025 | 39550253 | PubTator, text mining | PubMed |
| Glabridin inhibits proliferation and migration in hepatocellular carcinoma by regulating multi-targets. | J Ethnopharmacol | 2025 | 39510424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7538/papers?page=7